RecruitingNot ApplicableNCT06851988

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients


Sponsor

Chang Gung Memorial Hospital

Enrollment

180 participants

Start Date

May 3, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.


Eligibility

Min Age: 20 YearsMax Age: 80 Years

Inclusion Criteria5

  • Age ≥20
  • Pathology:Squamous cell carcinoma
  • Need CCRT treatment
  • ECOG PS\<2
  • Agree with blood drawing, excise training, questionnaire

Exclusion Criteria5

  • ECOG PS≥2
  • Unable to tolerate basic exercise, or CCRT treatment
  • Mental illness or any medical illness or concurrent illness that may be aggravated by exercise training or unmanageable
  • Any medical condition that unsuitable for exercise
  • Disagree to trial procedures: exercise, blood draws, questionnaire

Interventions

OTHERHIIT & Record of physical activities at home.

After CCRT treatment 4-5 week arrange HIIT excise for patient two to three times a week 24-36 times. And record of physical activities at home. According to the record set goal to acheive.

OTHERHIIT only

After CCRT treatment 4-5 week arrange HIIT excise for patient two to three times a week 24-36 times.


Locations(1)

TuCheng Hospital

New Taipei City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06851988


Related Trials